CSF1R and Alzheimer disease: However, despite numerous studies investigating the effects of depleting CSF1R-sensitive microglia on AD-associated pathological measures such as amyloid plaques, neuroinflammation, synaptic markers, and neurodegenerative phenotypes and gene expressions, there is limited understanding of how microglial depletion affects neural physiology and function in vivo in the context of AD.